Literature DB >> 32186660

Confirmatory Trial for Drug to Prevent Preterm Birth Finds No Benefit, So Why Is It Still Prescribed?

Rita Rubin.   

Abstract

Year:  2020        PMID： 32186660     DOI： 10.1001/jama.2020.1486

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  Targeted drug delivery for maternal and perinatal health: Challenges and opportunities.

Authors:  Anjali Sharma; Nirnath Sah; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Adv Drug Deliv Rev       Date:  2021-08-26       Impact factor: 17.873

2.  Sponsorship of Australian and New Zealand medical societies by healthcare companies: an observational study.

Authors:  Joel Lexchin
Journal:  JRSM Open       Date:  2022-07-07

3.  Enhanced drug delivery to the reproductive tract using nanomedicine reveals therapeutic options for prevention of preterm birth.

Authors:  Hannah C Zierden; Jairo I Ortiz; Kevin DeLong; Jingqi Yu; Gaoshan Li; Peter Dimitrion; Sabrine Bensouda; Victoria Laney; Anna Bailey; Nicole M Anders; Morgan Scardina; Mala Mahendroo; Sam Mesiano; Irina Burd; Gunter Wagner; Justin Hanes; Laura M Ensign
Journal:  Sci Transl Med       Date:  2021-01-13       Impact factor: 17.956

4.  The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives.

Authors:  Valeria Belleudi; Filomena Fortinguerra; Francesca R Poggi; Serena Perna; Renata Bortolus; Serena Donati; Antonio Clavenna; Anna Locatelli; Marina Davoli; Antonio Addis; Francesco Trotta
Journal:  Front Pharmacol       Date:  2021-06-23       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.